Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8633433 | Neuropeptides | 2017 | 7 Pages |
Abstract
In the MIA OA pain model, neuropeptide modulation appears early, and confirms the central nervous system to be an attractive target for OA pain quantification. The relationship of neuropeptide release with severity of cartilage lesions and functional assessment are promising and need further validation.
Keywords
NeuropeptidomicsSTTMIAATF-3PWTCGRPv/vw/vpaw withdrawal thresholdProbabilityOsteoarthritisstandard deviationbradykininvolume/volumestandard error of the meanPainDAYSomatostatinnociceptionNuclear factor-kappa BActivating transcription factor-3LidocaineSubstance PSEMIntra-articularweight/volumemonosodium iodoacetate
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Colombe Otis, Martin Guillot, Maxim Moreau, Johanne Martel-Pelletier, Jean-Pierre Pelletier, Francis Beaudry, Eric Troncy,